Health & Fit: FDA warns Canadian company about distributing 'potentially dangerous' drugs in US - - PressFrom - US
  •   
  •   
  •   

Health & FitFDA warns Canadian company about distributing 'potentially dangerous' drugs in US

21:45  01 march  2019
21:45  01 march  2019 Source:   cnn.com

Why Several Blood Pressure Drugs Are Being Recalled

Why Several Blood Pressure Drugs Are Being Recalled Joining a growing list of recalled medications, Teva Pharmaceuticals has now announced a voluntary recall of combination tablets containing valsartan.

The US Food and Drug Administration has issued a warning letter to the Canadian company CanaRx for playing a role in "the introduction of unapproved new drugs and misbranded drugs " to the United States .

The US Food and Drug Administration has issued a warning letter to the Canadian company "These drugs are potentially dangerous to U . S . consumers Importantly, they're also distributing drugs for which the FDA -approved versions are subject to additional safety requirements," he said.

FDA warns Canadian company about distributing 'potentially dangerous' drugs in US© Provided by Cable News Network, Inc. hm.medicine.cabinet_00000000

The US Food and Drug Administration has issued a warning letter to the Canadian company CanaRx for playing a role in "the introduction of unapproved new drugs and misbranded drugs" to the United States, according to the letter.

"These drugs are potentially dangerous to U.S. consumers," the FDA said in a news release Thursday.

An unapproved new drug has not been approved for use by the FDA. A misbranded drug fails to bear either adequate directions for its intended use or adequate warnings relating to its use.

CanaRx helps residents of the United States purchase medications from pharmacies in Canada, Australia and the United Kingdom, according to its website. The company has not responded to a request for comment.

All That Glitters is Not Edible, Warns FDA

All That Glitters is Not Edible, Warns FDA Festive season bakers have been urged to check glitter packets to ensure their glitter is meant to be eaten.

The US Food and Drug Administration has issued a warning letter to the Canadian company “These drugs are potentially dangerous to U . S . consumers,” the FDA said in a news release An unapproved new drug has not been approved for use by the FDA . A misbranded drug fails to bear

“These drugs are potentially dangerous to U . S . consumers,” the FDA said in a news release Thursday. An unapproved new drug has not been Some of the drugs received through the program treat hepatitis, cancer or HIV. The FDA letter warns that those are serious medical conditions and

Hundreds of the most commonly prescribed brand-name drugs are included in the CanaRx program, according to its website.

Some of the drugs received through the program treat hepatitis, cancer or HIV. The FDA letter warns that those are serious medical conditions and that side effects of drugs that may have been recalled, but still obtained through CanaRx, could be life-threatening.

The letter, sent Tuesday, also warns that certain drugs distributed by CanaRx may have different dosage strengths or trade names or be manufactured by different companies from versions of the drug that are FDA-approved and available in the United States.

"Such differences can cause patient confusion and lead to medication errors," according to the letter, which includes a list of more than 150 websites affiliated with CanaRx.

Certain antibiotics may cause aortic aneurysm, FDA warns

Certain antibiotics may cause aortic aneurysm, FDA warns The U.S. Food and Drug Administration warned on Thursday that the benefits of fluoroquinolone antibiotics do not outweigh the risks — which include aortic aneurysm — for certain patients.

The US Food and Drug Administration has issued a warning letter to the Canadian company CanaRx for playing a role in "the introduction of unapproved new drugs and Says new, unapproved drugs ' potentially dangerous '. Posted: 1:36 PM, March 01, 2019 Updated: 1:36 PM, March 01, 2019.

The US Food and Drug Administration has issued a warning letter to the Canadian company CanaRx for playing a role in "the introduction of unapproved new drugs and misbranded drugs " to the United Says new, unapproved drugs ' potentially dangerous '.

The warning letter was sent after a "lengthy review" of the drug distributor's practices, the FDA said.

"When a consumer goes online to buy medicines purportedly from Canada, they may get a medicine sourced from elsewhere that could be counterfeit, expired or misbranded. While operations or illegal online pharmacies may state on their websites that its medicines are coming from Canada, the United Kingdom, Australia, etc., this is not necessarily always the case," Commissioner Dr. Scott Gottlieb said in the news release.

"Such operations and illegal online pharmacies take advantage of unsuspecting Americans by purporting to distribute safe and effective imported drugs, at least some of which are instead expired, mislabeled, subject to recalls or potentially counterfeit and that are provided outside of the closed American distribution system meant to protect patient safety," Gottlieb said.

Transfusions Using Young People's Blood Could Be Dangerous, FDA Warns

Transfusions Using Young People's Blood Could Be Dangerous, FDA Warns Companies are offering blood transfusions using plasma from 16- to 25-year-olds as a way to fight aging and certain diseases. But the U.S. Food and Drug Administration has issued a statement warning this practice may be unsafe. 

The US Food and Drug Administration has issued a warning letter to the Canadian company CanaRx for playing a role in "the introduction of unapproved new drugs and Says new, unapproved drugs ' potentially dangerous '. Posted: 2:36 PM, March 01, 2019 Updated: 2:36 PM, March 01, 2019.

The US Food and Drug Administration has issued a warning letter to the Canadian company CanaRx for playing a role in "the introduction of unapproved new drugs and misbranded drugs " to the United Says new, unapproved drugs ' potentially dangerous '.

"Operations like CanaRx use their names to imply that patients are receiving medicines approved in Canada, when it's likely that patients are receiving medicines from other countries, and which may be sub-potent, super-potent or counterfeit. Importantly, they're also distributing drugs for which the FDA-approved versions are subject to additional safety requirements," he said. "These risk mitigation programs are a legal requirement and are in place for important safety reasons. Sidestepping them is unacceptable and puts the safety of patients in great jeopardy."

The warning letter calls for CanaRx to "promptly cease causing the distribution of unapproved new drugs and misbranded drugs to U.S. consumers and correct all other violations." The letter also requests that the company respond within 10 working days with details on how such violations have been or will be corrected.

FDA warns Canadian company about distributing 'potentially dangerous' drugs in US© Photo Illustration/Thinkstock You go through your closet to throw out clothes that are long past their fashion expiration date, but what about your medicine cabinet? If you have a bottle of prescription pain killers from an old surgery, toss them, says Ernest Boyd, executive director of the Ohio Pharmacists Association. "Don't tempt your children, grandchildren or even yourself with medicines that have the potential to start an addiction."You may also want to set up an appointment with your pharmacist to ask about the drugs you're currently taking, Boyd says. A pharmacist will be able to spot bad interactions between different prescriptions and may even be able to reduce the total number of drugs you need.
Read More

Sleep Drugs Like Ambien Will Get a New FDA Warning About Potentially Fatal Side Effects.
Some common sleep drugs will have to carry a serious warning about the rare, frightening side effects they can cause. The side effects, which have reportedly caused serious injuries and even deaths, include sleepwalking and other intricate behaviors done while a person is sleeping or not fully awake, like driving and cooking. The new black box warning—the strictest label used by the FDA to denote potentially life-threatening side effects—will apply to three drugs commonly used for insomnia and sold under various brand names.

—   Share news in the SOC. Networks

Topical videos:

usr: 1
This is interesting!